Categories
-
Adhesives
5
Amines
92
Amino Acids
179
Analytical Reagents
660
Antibiotics
247
Bioactive Small Molecules
713
Aroma Chemicals
203
Biochemicals
998
Boronic Acids
4
Buffers
96
Building Blocks
1762
Carbohydrates
176
Catalysts
96
Chiral Compounds
52
Coccus nucifera oil
0
Detergents
57
Diagnostic Raw Materials
253
Flavours and Fragrance Materials
202
Fluorinated Products
43
Furans
5
Gases in Solution
47
Grignard Reagents
18
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
323
Ion-Pair Reagents
24
Ligands
79
Organics
1290
Oxazoles
3
Peptide Reagents
90
Phenols
45
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
43
Reagents
96
Research Organics & Inorganics
746
Salts
282
Sealing Compounds
1
Sherclin
1
Solvents
121
Stains & Indicators
290
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
91
Water Analysis
11
Lopinavir
(89983914 | 192725-17-0)
CAS: | 192725-17-0 |
---|---|
Molecular Formula: | C37H48N4O5 |
Molecular Weight: | 628.80 |
Availablility: | In Stock |
---|---|
Downloads: | | |
89983914-250mg | 250mg | £62.10 | |
Bulk Order |
89983914-250mg | 250mg | €87.00 | |
Bulk Order |
89983914-250mg | 250mg | $93.20 | |
Bulk Order |
Safety Data Sheet
Certificate of Analysis
Product Detail
Product Code | 89983914 | ||||
Product Name | Lopinavir | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 192725-17-0 | ||||
Molecular Formula | C37H48N4O5 | ||||
Molecular Weight | 628.80 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 2933599590 |
Product Specification
Specific rotation | -22° to -26° | ||||
Heavy metals | ≤ 20 ppm | ||||
Identification | Conforms to reference (IR,HPLC) | ||||
Residue on Ignition | <0.2% | ||||
Sulfated ash | ≤ 0.2% | ||||
Appearance | White to off white powder | ||||
Water content ( KF) | ≤ 4.0% | ||||
Assay (HPLC ) | 98% -102% | ||||
Version | To report |
Safety Information
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|